Common Sense Ltd was founded in March 1999 by a team of experts in gynecology, chemistry and medical device engineering.
The company develops, manufactures and markets home tests for gynecological conditions. These products are based on a patented method for formulating a polymer sensitive to pH levels, buffer capacity and ammonia concentrations in bodily fluids. They enable patients to self-administer accurate, non-invasive tests and upgrade their health monitoring. The company’s first two products have been sold in 15 European countries. It is now developing two additional products, and performing the required tests to receive FDA approval and enter the US market.